We are live on ! Find out more
AIM

Alambic Investment Management Portfolio holdings

AUM $9.12M
1-Year Est. Return 34.55%
This Fund
S&P 500
This Quarter Est. Return
-2.11%
1 Year Est. Return
+34.55%
3 Year Est. Return
+47.56%
5 Year Est. Return
+107.87%
10 Year Est. Return
AUM
$718M
AUM Growth
-$113M
Cap. Flow
-$82.8M
Cap. Flow %
-11.53%
Top 10 Hldgs %
10.72%
Holding
577
New
129
Increased
141
Reduced
182
Closed
122

Sector Composition

Rank Sector Weight
1 Industrials 19.32%
2 Technology 19.27%
3 Consumer Discretionary 16.6%
4 Healthcare 11.95%
5 Materials 8.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ECYT
426
DELISTED
Endocyte, Inc. Common Stock
ECYT
$136K 0.02%
+14,947
New +$82.5K
ULBI icon
427
Ultralife
ULBI
$119M
$131K 0.02%
13,100
-3,300
-20% -$25.5K
RLH
428
DELISTED
Red Lions Hotel Corporation
RLH
$123K 0.02%
12,565
-9,957
-44% -$102K
ODP
429
DELISTED
ODP
ODP
$118K 0.02%
5,495
-7,955
-59% -$234K
ESND
430
DELISTED
Essendant Inc.
ESND
$118K 0.02%
+15,127
New +$130K
KODK icon
431
Kodak
KODK
$997M
$112K 0.02%
20,900
-60,000
-74% -$385K
XRM
432
DELISTED
Xerium Technologies Inc (new)
XRM
$112K 0.02%
+17,300
New +$91.8K
SCTL
433
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$111K 0.02%
11,195
-3,918
-26% -$32.9K
CGI
434
DELISTED
Celadon Group Inc
CGI
$109K 0.02%
29,516
NCMI icon
435
National CineMedia
NCMI
$248M
$103K 0.01%
1,990
-4,260
-68% -$281K
JASN
436
DELISTED
Jason Industries, Inc.
JASN
$99K 0.01%
+31,981
New +$85K
CDTX
437
DELISTED
Cidara Therapeutics
CDTX
$96K 0.01%
+1,200
New +$164K
ZIXI
438
DELISTED
Zix Corporation
ZIXI
$96K 0.01%
22,437
-70,371
-76% -$302K
AVEO
439
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
$95K 0.01%
3,291
-130
-4% -$3.8K
ASCMA
440
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
$94K 0.01%
25,520
+7,300
+40% +$55K
CRK icon
441
Comstock Resources
CRK
$4.2B
$88K 0.01%
+12,074
New +$97.5K
DALN
442
DELISTED
DallasNews
DALN
$84K 0.01%
+4,075
New +$82.3K
ELMD icon
443
Electromed
ELMD
$348M
$83K 0.01%
15,572
+200
+1% +$1.16K
RFL icon
444
Rafael Holdings
RFL
$99.8M
$75K 0.01%
+15,616
New +$73.9K
BBQ
445
DELISTED
BBQ Holdings, Inc. Common Stock
BBQ
$74K 0.01%
+10,405
New +$69.6K
FLL icon
446
Full House Resorts
FLL
$86.8M
$60K 0.01%
18,619
+8,619
+86% +$28.6K
HBIO icon
447
Harvard Bioscience
HBIO
$28.1M
$54K 0.01%
+1,080
New +$48.4K
STRR
448
DELISTED
Star Equity Holdings
STRR
$48K 0.01%
+622
New +$69.3K
INVE icon
449
Identive
INVE
$66M
$40K 0.01%
+10,600
New +$39.5K
PFIE
450
DELISTED
Profire Energy, Inc
PFIE
$40K 0.01%
+14,592
New +$33.1K

Similar funds

Alambic Investment Management's Q1 2018 Portfolio in Review

As of Q1 2018, Alambic Investment Management held 577 positions worth $718M, down 14% from $831M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alambic Investment Management withdrew a net $82.8M in Q1 2018, closing 122 positions and reducing 182 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $7.81M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Alambic Investment Management opened a new position in Tenneco Inc. Class A Voting Common Stock worth $4.8M.

  • Alambic Investment Management's largest Q1 2018 buy was Tenneco Inc. Class A Voting Common Stock: 87,500 shares worth $4.8M.
  • Alambic Investment Management added most to Strategy Inc in Q1 2018, an estimated $5.92M increase.
  • Alambic Investment Management's biggest Q1 2018 reduction was Greif, cutting an estimated $6.6M.
  • Alambic Investment Management fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $7.81M.
  • Alambic Investment Management's ten largest holdings make up 11% of its $718M portfolio in Q1 2018.
  • Alambic Investment Management opened 129 new positions and closed 122 in Q1 2018.
  • Alambic Investment Management's portfolio value fell 14% quarter-over-quarter to $718M.

Based on Alambic Investment Management's 13F filing for Q1 2018, filed 8 May 2018.